3JDouma RA, Kamphuisen PW, Biiller HR. Acute pulmonaryembolism. Part 1: epidemiology and diagnosis. Nat RevCardiol, 2010, 7(10):585-596.
4Lankeit M, Konstantinides S. Mortality risk assessment and therole of thrombolysis in pulmonary embolism. Clin Chest Med,2010,31(4): 759-769.
5Hochhegger B,Ley-Zaporozhan J, Marchiori E, et al. Magneticresonance imaging findings in acute pulmonary embolism. Br JRadiol, 2011,84(999): 282-287.
6Chairperson AT, Perrier A, Kanstantinides S, et al. Guidelineson the diagnosis and management of acute pulmonaryembolism. Eur Heart J, 2008, 29: 2276-2315.
7Tsimogianni AM, Rovina N, Porfyridis I,et al. Clinicalprediction of pulmonary embolism in respiratory emergencies.Thromb Res,2011, 127(5):411-417.
8Carrier M, Righini M, Djurabi RK, et al. VIDAS D-dimerin combination with clinical pre-test probability to rule outpulmonary embolism: a systematic review of managementoutcome studies. Thromb Haemost, 2009, 101(5): 886-892.
9Cosmi B, Legnani C, Tosetto A, et al. Sex, age and normalpost-anticoagulation D-dimer as risk factors for recurrenceafter idiopathic venous thromboembolism in the Prolong studyextension. J Thromb Haemost, 2010, 8(9): 1933-1942.
10Sostman HD, Miniati M, Gottschalk A, et al. Sensitivity andspecificity of perfusion scintigraphy combined with chestradiography for acute pulmonary embolism in PIOPED II. JNucl Med, 2008, 49(11): 1741-1748.
